Product Information
ALLOPURINOL 300 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0567 per EA under NDC 00904657261. Its NADAC has been published 487 times since Mar 1, 2017.
Strength
300 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904657261
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ALLOPURINOLApproval Type
Generic (ANDA)
FDA Application
ANDA075798On Market Since
6/27/2003
Pharmacological Classes
Price Statistics
The NADAC for ALLOPURINOL 300 MG TABLET has been published 487 times since Mar 1, 2017, and over the history we have for it it has declined 77.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0567 per EA |
|---|---|
| All-time high | $0.2558 (Mar 15, 2017) |
| All-time low | $0.0552 (Apr 22, 2026) |
| 52-week high | $0.0674 |
| 52-week low | $0.0552 |
| Median price | $0.0902 |
| Average price | $0.1047 |
| Largest weekly change | -17.2% (Dec 20, 2017) |
| Weeks tracked | 487 |
| Tracking since | Mar 1, 2017 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ALLOPURINOL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALLOPURINOL 300 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0567 per EA (NDC 00904657261), effective Jun 24, 2026.
How has the price of ALLOPURINOL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALLOPURINOL 300 MG TABLET has declined 77.8%. It has been tracked across 487 weekly CMS publications since Mar 1, 2017.
What are the highest and lowest recorded NADAC prices for ALLOPURINOL 300 MG TABLET?
Since Mar 1, 2017, the NADAC for ALLOPURINOL 300 MG TABLET has ranged from a low of $0.0552 (Apr 22, 2026) to a high of $0.2558 (Mar 15, 2017), with a median of $0.0902 per EA.
Are there cheaper alternatives to ALLOPURINOL 300 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as ALLOPURINOL 300 MG TABLET, but none are currently priced below it.
Who manufactures ALLOPURINOL 300 MG TABLET?
ALLOPURINOL 300 MG TABLET (NDC 00904657261) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification